Found 271 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is A  [Clear All Filters]
2018
R. K. Kasimanickam, Hall, J. B., Estill, C. T., Kastelic, J. P., Joseph, C., Aziz, R. L. Abdel, and Nak, D., Flunixin meglumine improves pregnancy rate in embryo recipient beef cows with an excitable temperament., Theriogenology, vol. 107, pp. 70-77, 2018.
T. Laver, Feldhaeusser, B. R., Robat, C. S., Baez, J. L., Cronin, K. L., Buracco, P., Annoni, M., Regan, R. C., McMillan, S. K., Curran, K. M., Selmic, L. E., Shiu, K. - B., Clark, K., Fagan, E., and Thamm, D. H., Post-surgical outcome and prognostic factors in canine malignant melanomas of the haired skin: 87 cases (2003-2015)., Can Vet J, vol. 59, no. 9, pp. 981-987, 2018.
J. V. Brady, Troyer, R. M., Ramsey, S. A., Leeper, H., Yang, L., Maier, C. S., Goodall, C. P., Ruby, C. E., Albarqi, H. A. M., Taratula, O., and Bracha, S., A Preliminary Proteomic Investigation of Circulating Exosomes and Discovery of Biomarkers Associated with the Progression of Osteosarcoma in a Clinical Model of Spontaneous Disease., Transl Oncol, vol. 11, no. 5, pp. 1137-1146, 2018.
S. Al-Nadaf, Rebhun, R. B., Curran, K. M., Venable, R. O., Skorupski, K. A., Willcox, J. L., and Burton, J. H., Retrospective analysis of doxorubicin and prednisone as first-line therapy for canine B-cell lymphoma., BMC Vet Res, vol. 14, no. 1, p. 356, 2018.
C. C. Otoni, Heilmann, R. M., García-Sancho, M., Sainz, A., Ackermann, M. R., Suchodolski, J. S., Steiner, J. M., and Jergens, A. E., Serologic and fecal markers to predict response to induction therapy in dogs with idiopathic inflammatory bowel disease., J Vet Intern Med, vol. 32, no. 3, pp. 999-1008, 2018.
K. Chi Lam, Vyshenska, D., Hu, J., Rodrigues, R. Rosario, Nilsen, A., Zielke, R. A., Brown, N. Samuel, Aarnes, E. - K., Sikora, A. E., Shulzhenko, N., Lyng, H., and Morgun, A., Transkingdom network reveals bacterial players associated with cervical cancer gene expression program., PeerJ, vol. 6, p. e5590, 2018.
2017
K. M. Curran, Schaffer, P. A., Frank, C. B., Lana, S. E., Hamil, L. E., Burton, J. H., Labadie, J., Ehrhart, E. J., and Avery, P. R., BCL2 and MYC are expressed at high levels in canine diffuse large B-cell lymphoma but are not predictive for outcome in dogs treated with CHOP chemotherapy., Vet Comp Oncol, vol. 15, no. 4, pp. 1269-1279, 2017.
L. V. Austin, Budischak, S. A., Ramadhin, J., Hoberg, E. P., Abrams, A., Jolles, A. E., and Ezenwa, V. O., A comparison of two methods for quantifying parasitic nematode fecundity., Parasitol Res, vol. 116, no. 5, pp. 1597-1602, 2017.
L. V. Austin, Budischak, S. A., Ramadhin, J., Hoberg, E. P., Abrams, A., Jolles, A. E., and Ezenwa, V. O., A comparison of two methods for quantifying parasitic nematode fecundity., Parasitol Res, vol. 116, no. 5, pp. 1597-1602, 2017.
Y. Echigoya, Nakamura, A., Nagata, T., Urasawa, N., Lim, K. Rowel Q., Trieu, N., Panesar, D., Kuraoka, M., Moulton, H. M., Saito, T., Aoki, Y., Iversen, P., Sazani, P., Kole, R., Maruyama, R., Partridge, T., Takeda, S. 'ichi, and Yokota, T., Effects of systemic multiexon skipping with peptide-conjugated morpholinos in the heart of a dog model of Duchenne muscular dystrophy., Proc Natl Acad Sci U S A, vol. 114, no. 16, pp. 4213-4218, 2017.
P. S. Askovich, Ramsey, S. A., Diercks, A. H., Kennedy, K. A., Knijnenburg, T. A., and Aderem, A., Identifying novel transcription factors involved in the inflammatory response by using binding site motif scanning in genomic regions defined by histone acetylation., PLoS One, vol. 12, no. 9, p. e0184850, 2017.
P. S. Askovich, Ramsey, S. A., Diercks, A. H., Kennedy, K. A., Knijnenburg, T. A., and Aderem, A., Identifying novel transcription factors involved in the inflammatory response by using binding site motif scanning in genomic regions defined by histone acetylation., PLoS One, vol. 12, no. 9, p. e0184850, 2017.
N. P. Manes, Shulzhenko, N., Nuccio, A. G., Azeem, S., Morgun, A., and Nita-Lazar, A., Multi-omics Comparative Analysis Reveals Multiple Layers of Host Signaling Pathway Regulation by the Gut Microbiota., mSystems, vol. 2, no. 5, 2017.
R. White, Atherly, T., Guard, B., Rossi, G., Wang, C., Mosher, C., Webb, C., Hill, S., Ackermann, M. R., Sciabarra, P., Allenspach, K., Suchodolski, J., and Jergens, A. E., Randomized, controlled trial evaluating the effect of multi-strain probiotic on the mucosal microbiota in canine idiopathic inflammatory bowel disease., Gut Microbes, vol. 8, no. 5, pp. 451-466, 2017.
R. White, Atherly, T., Guard, B., Rossi, G., Wang, C., Mosher, C., Webb, C., Hill, S., Ackermann, M. R., Sciabarra, P., Allenspach, K., Suchodolski, J., and Jergens, A. E., Randomized, controlled trial evaluating the effect of multi-strain probiotic on the mucosal microbiota in canine idiopathic inflammatory bowel disease., Gut Microbes, vol. 8, no. 5, pp. 451-466, 2017.
R. White, Atherly, T., Guard, B., Rossi, G., Wang, C., Mosher, C., Webb, C., Hill, S., Ackermann, M. R., Sciabarra, P., Allenspach, K., Suchodolski, J., and Jergens, A. E., Randomized, controlled trial evaluating the effect of multi-strain probiotic on the mucosal microbiota in canine idiopathic inflammatory bowel disease., Gut Microbes, vol. 8, no. 5, pp. 451-466, 2017.
D. Roymans, Alnajjar, S. S., Battles, M. B., Sitthicharoenchai, P., Furmanova-Hollenstein, P., Rigaux, P., Van den Berg, J., Kwanten, L., Van Ginderen, M., Verheyen, N., Vranckx, L., Jaensch, S., Arnoult, E., Voorzaat, R., Gallup, J. M., Larios-Mora, A., Crabbe, M., Huntjens, D., Raboisson, P., Langedijk, J. P., Ackermann, M. R., McLellan, J. S., Vendeville, S., and Koul, A., Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor., Nat Commun, vol. 8, no. 1, p. 167, 2017.
D. Roymans, Alnajjar, S. S., Battles, M. B., Sitthicharoenchai, P., Furmanova-Hollenstein, P., Rigaux, P., Van den Berg, J., Kwanten, L., Van Ginderen, M., Verheyen, N., Vranckx, L., Jaensch, S., Arnoult, E., Voorzaat, R., Gallup, J. M., Larios-Mora, A., Crabbe, M., Huntjens, D., Raboisson, P., Langedijk, J. P., Ackermann, M. R., McLellan, J. S., Vendeville, S., and Koul, A., Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor., Nat Commun, vol. 8, no. 1, p. 167, 2017.
D. Roymans, Alnajjar, S. S., Battles, M. B., Sitthicharoenchai, P., Furmanova-Hollenstein, P., Rigaux, P., Van den Berg, J., Kwanten, L., Van Ginderen, M., Verheyen, N., Vranckx, L., Jaensch, S., Arnoult, E., Voorzaat, R., Gallup, J. M., Larios-Mora, A., Crabbe, M., Huntjens, D., Raboisson, P., Langedijk, J. P., Ackermann, M. R., McLellan, J. S., Vendeville, S., and Koul, A., Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor., Nat Commun, vol. 8, no. 1, p. 167, 2017.

Pages